Stanford University
Showing 5,651-5,700 of 13,128 Results
-
Juliann Lipps Kim
Adjunct Clinical Professor, Pediatrics - General Pediatrics
BioDr. Juliann Kim works as a Pediatric Hospitalist for PAMF. She cares for patients in the LPCH Newborn Nursery, Packard Intermediate Care Nursery, and on the inpatient wards. She serves on several LPCH committees including Professional Performance Evaluation Committee, Perinatal Care Committee, Credentials Committee, and Care Improvement Committee. She served as the LPCH Medical Staff President from 2018-2020.
-
Juyong Brian Kim
Assistant Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsThe lifetime risk of developing cardiovascular disease (CVD) is determined by the genetic makeup and exposure to modifiable risk factors. The Cardiovascular Link to Environmental ActioN (CLEAN) Lab is interested in understanding how various environmental pollutants (eg. tobacco, e-cigarettes, air pollution and wildfire) interact with genes to affect the transcriptome, epigenome, and eventually disease phenotype of CVD. The current focus is to investigate how different toxic exposures can adversely remodel the vascular wall leading to increased cardiac events. We intersect human genomic discoveries with animal models of disease, in-vitro and in-vivo systems of exposure, single-cell sequencing technologies to solve these questions. Additionally, we collaborate with various members of the Stanford community to develop biomarkers that will aid with detection and prognosis of CVD. We are passionate about the need to reduce the environmental effects on health through strong advocacy and outreach.
(http://kimlab.stanford.edu) -
Kaitlyn Kim
Masters Student in Translational Research and Applied Medicine, admitted Autumn 2025
Stanford Student Employee, Health PolicyCurrent Research and Scholarly InterestsCancer Immunotherapy, Solid Tumors, Early-Stage Neurodegeneration, Healthy Aging, Sleep Dysregulation.
-
Kyung Mi Kim
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioKyung Mi Kim, PhD, RN, is a Clinical Assistant Professor at Stanford University, School of Medicine. She has expertise in quantitative methods, including econometrics, large data analysis, and the evaluation of value-based payment policies. She is passionate about care models that lower the cost of high-quality care for frail, older surgical patients and their caregivers, partnering with leaders in health care, science, and technology to achieve the greatest impact.
-
Nathan Geonwoo Kim, MD, MS
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Nathan Geonwoo Kim is a board-certified, fellowship-trained transplant hepatologist with Stanford Health Care. He is also a clinical assistant professor in the Department of Medicine, Division of Gastroenterology & Hepatology at Stanford University School of Medicine.
Dr. Kim specializes in hepatology and liver transplantation (transplant hepatology). He cares for people with severe liver disease, such as cirrhosis, alcohol-associated hepatitis, and metabolic dysfunction-associated steatotic liver disease. Dr. Kim also provides personalized liver cancer care, which may include targeted therapies or liver transplantation to achieve the best possible outcomes.
With a Master of Science in epidemiology and clinical research, Dr. Kim studies hepatocellular carcinoma and outcomes in chronic liver disease. His research focuses on ways to deliver better, more equitable care to people with liver diseases.
Dr. Kim has published his findings in leading medical journals, including the Journal of Hepatology, Clinical Gastroenterology and Hepatology, and Cancer. He has also shared his expertise at national and international conferences, including Digestive Disease Week, The Liver Meeting, and the International Liver Congress. -
Paige Livingston, PA-C
Physician Assistant - Research, Medicine - Med/Blood and Marrow Transplantation
BioPaige has an undergraduate degree in Nutrition from Cal Poly, SLO and completed her Master’s degree in Physician Assistant Studies at Western University of Health Sciences in Southern California before moving to the bay area in November 2016 to join the Stanford Bone Marrow Transplant & Cancer Cell Therapy team. She believes in providing quality care with compassion, taking time to listen to patients and families and helping them navigate complex medical situations and decisions. She has lead the project for APP involvement in Bone Marrow Harvests and serves on the planning committee for a local APP Oncology conference. Her area of clinical practice is bone marrow transplantation and cancer cell therapy.
-
Peter S. Kim
Virginia and D. K. Ludwig Professor of Biochemistry
Current Research and Scholarly InterestsOur research focuses on developing new strategies for vaccine creation. We also aim to generate vaccines targeting infectious agents that have eluded efforts to date. We integrate experimental approaches with protein language models to guide artificial evolution and enable efficient antibody and protein engineering. Our interdisciplinary approach aims to address critical global health challenges.
-
Richard K. Kim
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Richard K. Kim is a board-certified anesthesiologist and Clinical Associate Professor in the Department of Anesthesiology, Perioperative and Pain Medicine. He is fellowship-trained in regional anesthesiology and acute pain medicine (RAAPM), with clinical expertise centered on ultrasound-guided peripheral nerve and truncal/fascial plane blocks, neuraxial techniques, and the perioperative management of acute and complex surgical pain.
As a mentor, he has garnered numerous teaching awards, including the RAAPM Fellowship Teacher of the Year Award. He is actively involved in shaping education for anesthesiology, leveraging evidence-based medicine and clinical informatics to reinforce standards of care while advancing novel approaches to anesthesia.
His scholarly work explores the safety, efficacy, and implementation of regional anesthesia and multimodal analgesia in complex patient care settings, with ongoing work supported by the NIH. This continues to inform consultations and collaborations on questions at the intersection of anesthesia practice, emerging technology, and perioperative pain management.
His administrative work focuses on clinical documentation integrity and the alignment of anesthesia practice with procedural and regulatory standards. -
Samsuk Kim, PhD.
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioDr. Samsuk Kim is a dual research and clinical T32 fellow at Stanford University. She earned her PhD in Clinical Psychology from the University of Detroit Mercy and completed external research training at the University of Michigan (Kratz Lab), where she studied psychosocial factors—such as mindfulness and pain acceptance—in chronic pain. She also completed an APA-accredited internship at the VA Boston Healthcare System. Clinically, Dr. Kim specializes in pain management, health promotion, adjustment-related challenges, and emotional regulation. She draws from a range of evidence-based treatments, including Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), mindfulness-based interventions, Dialectical Behavior Therapy (DBT), and interpersonal psychotherapy. Her current research focuses on understanding the bidirectional relationship between sleep and pain and developing personalized, digital interventions to improve outcomes in both domains.
-
Seung K. Kim M.D., Ph.D.
KM Mulberry Professor, Professor of Developmental Biology, of Medicine (Endocrinology) and, by courtesy, of Pediatrics (Endocrinology)
Current Research and Scholarly InterestsPancreatic islets are essential for human health. We study the development and function of islet cells using modern methods in several model systems, including mice, pigs, human pancreas, primates, embryonic stem cells, and fruit flies. We have discovered critical factors required for islet development and mature islet cell function. These approaches have informed efforts to generate replacement islets, and provide immune protection of transplanted islets for diabetes.
-
Stuart Kim
Professor of Developmental Biology, Emeritus
Current Research and Scholarly InterestsMechanisms of Aging in C. elegans and humans.
-
Sun Kim, M.D. M.S.
Associate Professor of Medicine (Endocrinology)
Current Research and Scholarly InterestsWe are interested in studying the pathophysiological processes that contribute to glucose intolerance and type 2 diabetes mellitus. My current research focuses on characterizing pancreatic beta-cell function in populations with significant insulin resistance and vulnerability to developing diabetes: individuals with schizophrenia, morbid obesity, and history of gestational diabetes.
-
Sunhee S. Kim, MD
Clinical Assistant Professor, Surgery - General Surgery
BioDr. Sunhee Serenity Kim is a board-certified, fellowship-trained general surgeon at Stanford Health Care and clinical assistant professor in the Department of Surgery, Division of General Surgery at Stanford University School of Medicine. She is also the director of emergency general surgery and clinical medical director of the general surgery outpatient clinic at Stanford Health Care Tri-Valley.
Dr. Kim specializes in acute care surgery, applying minimally invasive surgical approaches such as robotic surgery. Dr. Kim treats a broad range of diseases, including gallbladder disease, diverticular disease, ventral and inguinal hernias, and benign breast disease. She has particular interest in enteroatmospheric and enterocutaneous fistula treatment.
Dr. Kim’s research interests have included cytokinesis, rare genetic mutations in blood cancers, and surgical treatment outcomes in people with pancreatic cancer. Most recently, she has performed clinical research with trauma and emergency general surgery patients.
Dr. Kim has published her research in peer-reviewed journals, including The American Journal of Surgical Pathology, Journal of the National Cancer Institute, Nature Communications, and Proceedings of the National Academy of Sciences. She has also presented to her peers at national meetings, including annual meetings of the Society of Surgical Oncology, American Society of Clinical Oncology, and Association for Academy Surgery.
Dr. Kim is a member of the American College of Surgeons (ACS). -
Yeuen Kim
Clinical Associate Professor, Medicine - Vaden Health Center
BioYeuen Kim MD MAS is an internal medicine physician with expertise in population health, medical humanities educational interventions, and working with vulnerable populations in urban settings. She trained at Brown University's Program in Liberal Medical Education and completed residency/chief residency at the Santa Clara Valley Medical Center in San Jose, CA. She has worked with vulnerable populations in ambulatory and mobile settings as a primary care attending and medical outreach physician, as well as completing a Masters' and fellowship in clinical research at UCSF's Department of Biostatistics and Epidemiology & SFGH DGIM, where she evaluated electronic referrals to subspecialty clinics from safety settings (Kim, Chen et al, JGIM 2009.) She worked with the SF and Santa Clara County public health departments to help reduce mortality and improve COVID19 and mpox mitigation, especially at congregate residential facilities through better ventilation, public-private collaboration, and addressing determinants of health for essential workers. Since 2013, she has facilitated art gallery-based workshops for physicians and learners to improve observation and communication skills. She co-leads narrative medicine and oncology workshops for students, residents (Edwards, Kim et al, BMJ Educ 2022) and faculty as a clinical associate professor in Primary care and population health.
-
Yo Sup Kim
Clinical Scholar, Radiology
BioI completed both my diagnostic radiology residency at Indiana University School of Medicine and my MBA at the Kelley School of Business Indiana University on June 2025. I am currently pursuing my fellowship in Musculoskeletal Radiology at Stanford. My healthcare-related interests and research primarily involve applying real world business practices in radiology for optimal efficiency and maximizing value (e.g. using linear regression analysis to finding variables that impact volume of CT studies at the ER). Outside of healthcare, I have entrepreneurial interests particularly in the area of venture capitalism for tech and service companies. Prior to medical school, I ran my family's floral bouquet company in California.
-
Yong Yean Kim
Assistant Professor of Pediatrics ( Hematology & Oncology)
BioOur lab is interested in translational science to bring new therapies to clinical trials. In particular, we are interested in pediatric sarcomas which have not had advancement in clinical treatment for decades. Current projects in the lab focus on understanding of the biology of fusion transcription factor PAX3::FOXO1 which is the driver mutation in fusion positive rhabdomyosarcoma. PAX3::FOXO1 is a powerful oncogenic transcription factor which rewires the transcriptional organization to lock the cancer cell in the proliferative state. Since transcription factors including PAX3::FOXO1 are difficult to target using small molecules, we aim to understand how PAX3::FOXO1 is regulated and targeting the regulators of PAX3::FOXO1. By understanding and targeting the regulation of PAX3::FOXO1, we hope to bring new therapies for fusion positive rhabdomyosarcoma. Additionally, these regulatory mechanisms may also be active in other transcription driven cancers such as the EWSR1::FLI1 driven Ewings Sarcoma.
Our lab is also interested in exploring the epigenetic landscape of pediatric solid tumors and trying to understand how dysregulation in the epigenome drives oncogenesis. We utilize various CRISPR mediated genetic techniques to interrogate the regulators of epigenome focusing on the histone lysine demethylases (KDMs). KDMs are an understudied group of epigenetic regulators which can be targeted for therapeutic effect. We explore the role of KDMs in pediatric solid tumors and hope to identify potential targets for drug development.
